ADRC News

Medications typically used to treat diabetes are showing promise of treating Alzheimer’s disease. They have had positive results in slowing down the effects of Alzheimer’s disease in animals. 

 “…Can these drugs that we use to treat a condition we know about—diabetes, can these drugs also be used to reduce the risk of Alzheimer’s disease,” said Dr. Cynthia Carlsson, who was featured in the WAOW Newsline 9 article. 

However, since these drugs aren’t being used to...

More than 40 students, trainees, postdocs, fellows, and junior faculty members from across the UW-Madison campus submitted scientific abstracts to the poster session held in conjunction with the 2018 Alzheimer’s Disease & Related Disorders Research Day. The event took place March 23, 2018, at the Discovery Building on the UW-Madison campus. Three top abstracts were chosen for oral presentations, and the top three poster presenters were selected for Best Poster awards.

The following authors offered podium...

Community members are invited to a free community talk and memory screening presented by the Wisconsin Alzheimer’s Disease Research Center on February 16 and 17.

The event is planned for February (African American History Month) and named after Solomon Carter Fuller, the nation’s first African American psychiatrist and a pioneer in Alzheimer’s disease research.

African-Americans are twice as likely to develop Alzheimer’s disease compared to Caucasians.

The 8th annual Solomon Carter Fuller Memory Screening event starts...

The Wisconsin Alzheimer’s Disease Research Center invites campus researchers to submit their poster abstracts for the 2018 Alzheimer’s Disease & Related Disorders Research Day poster session. The call for posters is open to students of all levels, trainees, researchers, and faculty who are involved in basic, translational, clinical, and health services research related to Alzheimer’s disease, dementia, aging, and related topics.

Poster abstracts are due Wednesday, February 21, 2018, and can be submitted through online application. Accepted poster...

Dr. Nathaniel Chin spoke with NBC 15 on what inspired him to start “Dementia Matters,” a new podcast created by the Wisconsin Alzheimer's Disease Research Center. The podcast aims to take scientific information and break it down in a way that is easy to understand in order to reach as many people as possible. A new podcast is published every other Tuesday.

Chin, whose father was diagnosed with Alzheimer's disease, says his father inspired him to make...

Fish oil has been found to potentially lower triglycerides, lower cholesterol, and improve blood vessel function. Due to these effects, some believe it might also help prevent or delay Alzheimer’s disease.

A new study led by Dr. Cynthia Carlsson at UW Health and the William S. Middleton Memorial Veterans Hospital seeks to examine if veterans with a parental history of Alzheimer’s disease might be positively affected by a prescription high dose of fish oil, specifically...

The Madison VA is already a leader in geriatric care, as it is one of only 20 Veterans Administration hospitals that supports a Geriatric Research Education and Clinical Center (GRECC). However, on Monday, November 27, the hospital took its leadership in geriatric care one step further, as the William S. Middleton Memorial Veterans Hospital was recognized as the first VA in the country to achieve “Dementia Friendly Hospital” Status. In order to become a Dementia...

It’s estimated that in the coming decades, approximately 450,000 veterans will be diagnosed with Alzheimer’s disease. Veterans, especially VA-eligible veterans, are at a higher risk for developing dementia than the general public. Scientists have been unable to pinpoint the cause for this increased risk, but Dr. Cynthia Carlsson, a geriatrics provider at the William S. Middleton Memorial Veterans Hospital and researcher in the Wisconsin Alzheimer’s Disease Research Center, suggests it could be connected to an increased...

5.5 million Americans are currently living with Alzheimer’s disease and this this number is estimated to quadruple by 2050. Considering this, in addition to the fact that Alzheimer’s disease is currently costing the nation $259 billion annually in healthcare costs and that Alzheimer’s disease related deaths have jumped 55% in the past 15 years, finding a cure or preventative measures is becoming more and more important. Dr. Cynthia Carlsson expressed this when she appeared in...

The Wisconsin ADRC was featured in Brava Magazine’s recent article on Alzheimer’s disease in the Madison area. In Wisconsin, Alzheimer’s currently affects 120,000 people and took 2,085 lives in 2016. Nationally, Alzheimer’s and other dementias will cost $259 billion in 2017, and this sum is expected to reach $1.1 trillion by 2050. Yet, researchers at UW are optimistic, as there has been great advances in Alzheimer’s research in the last five years and believe they...